CD36, CD36 molecule, 948

N. diseases: 304; N. variants: 34
Source: BEFREE ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE Our results conclude that IL-34 facilitates foam cell formation by increasing CD36-mediated lipid uptake and suggest a potential new risk biomarker for atherosclerosis. 30478377 2018
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 AlteredExpression disease BEFREE Vim<sup>-/-</sup> mice displayed decreased atherogenesis despite increased vascular inflammation and increased CD36 expression on macrophages in two mouse models of atherosclerosis. 30451917 2018
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 AlteredExpression disease BEFREE All of these results demonstrated that FSTL3 as a novelty cytokine takes part in the process of atherosclerosis through increasing lipid accumulation and inflammation through regulating CD36 and LOX-1 expression. 31815869 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 AlteredExpression disease BEFREE Rcan1 regulates CD36 expression and its genetic inactivation reduced atherosclerosis extension and severity in Apoe(-/-) mice. 24127415 2013
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE Our findings indicated that myricetin suppressed cholesterol accumulation in macrophage foam cells by inhibition of CD36-mediated ox-LDL uptake, and suggested myricetin may have an important therapeutic function for atherosclerosis. 31049071 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors. 20634212 2010
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE In rodents, CD36 is implicated in abnormal lipid metabolism, inflammation and atherosclerosis. 20935172 2011
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE Macrophage scavenger receptors, such as CD36 and class A scavenger receptor (SR-A), have previously been thought to play a central role in foam cell formation and atherogenesis by mediating the uptake of oxidized LDL.In this issue of the JCI, Moore et al. report that Apoe mice deficient in either CD36 or SR-A did not have less atherosclerosis at the level of the aortic valve than did wild-type Apoe mice. 16075051 2005
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE Scavenger receptor CD36 is associated with increasing risk of diabetes and atherosclerosis, and may play a role in cognitive deficits. 28883843 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 AlteredExpression disease BEFREE The blocking of autophagy-lysosome induction could increase CD36 protein level, foam-cell formation, and migration, thus abolishing the protective effects of CTRP13 on atherosclerosis. 30222079 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE Both S100A12 and CD36 are implicated in vascular inflammation and atherosclerosis. 28756107 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE Recent literature has implicated CD36 in the pathogenesis of metabolic dysregulation such as found in obesity, insulin resistance, and atherosclerosis. 21250778 2011
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE Thus, targeting to CD36 and its downstream effectors may serve as potential new strategies against chronic inflammatory diseases such as atherosclerosis. 31625810 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. 11795270 2001
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 AlteredExpression disease BEFREE Azapeptide analogues of growth hormone-releasing peptide-6 (His-d-Trp-Ala-Trp-d-Phe-Lys-NH<sub>2</sub>, GHRP-6) have for example been pursued as ligands of the cluster of differentiation 36 receptor (CD36) and show promising activity for the development of treatments for angiogenesis-related diseases, such as age-related macular degeneration, as well as for atherosclerosis. 28598597 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 AlteredExpression disease BEFREE The expression of CD36 in macrophages promotes the accumulation of cholesterol, the development of foam cells, and ultimately atherosclerosis. 16822947 2006
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 AlteredExpression disease BEFREE Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis. 29474941 2018
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE We found that allergic asthma increased the expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) in the liver and CD36 in the aorta during the acute and advanced stages of atherosclerosis, respectively. 31558320 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE These findings indicate that caveolae and CD36 are involved in native LDL endocytosis and suggest that CD36 might be a good candidate for the transport of native LDL across the endothelium, an early event in atherosclerosis. 30768959 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE CD36 is associated with regulation of lipid metabolism, atherosclerosis, and blood pressure. 31185924 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 GeneticVariation disease BEFREE To search for associations between the CD36 gene polymorphisms and radiological markers of atherosclerosis progress in Caucasian patients with coronary artery disease (CAD) diagnosed at a young age. 22993001 2012
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE In hematopoietic cells, CD36 signaling enhances platelet dysfunction thus decreasing the threshold for platelet activation and accelerating arterial thrombosis, whereas in macrophages, CD36 promotes lipid-laden foam cell formation and atherosclerosis. 30825500 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE Deficiency of CD36 on hematopoietic cells diminished the effect of air pollution on 7-KCh accumulation, foam cell formation, and atherosclerosis. 25186795 2014
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 Biomarker disease BEFREE The present study aimed to explore whether PM<sub>2.5</sub>-exacerbated atherosclerosis was mediated by the cooperation of cluster of differentiation 36 (CD36) and nucleotide-binding oligomerization domain-like receptor protein (NLRP3) inflammasome in apolipoprotein E<sup>-/-</sup> (ApoE<sup>-/-</sup>) mice. 29571893 2018
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.300 AlteredExpression disease BEFREE In understanding the mechanisms of cholesterol in the pathogenesis of atherosclerosis, previous studies from other laboratories have demonstrated that cholesterol crystals (CC) induce scavenger receptor CD36 expression and NLRP3-mediated inflammasome formation. 28040583 2017